Diabetes: Type 1 diabetes mellitus-a door opening to a real therapy?

Nature Reviews Endocrinology

Volumn 7, Issue 10, 2011, Pages 564-566

  Chatenoud, Lucienne ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE VACCINE; TEPLIZUMAB; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG EFFICACY; HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL, HUMANIZED; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOCONJUGATES; IMMUNOTHERAPY;

EID: 80053149229     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.148     Document Type: Article

References (10)

1. Fadda, G. et al. Follicular thyroid neoplasms can be classified as low-and high-risk according to HBME-1 and galectin-3 expression on liquid-based fine-needle cytology. Eur. J. Endocrinol. 165, 447-453 (2011).
2. British Thyroid Association and Royal College of Physicians. Guidelines for the management of thyroid cancer, 2nd edn [online]. www. britishthyroid association.org/news/Docs/Thyroid-cancer-guidelines-2007pdf (2007).
3. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167-1214 (2009).
4. Gharib, H. et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J. Endocrinol. Invest. 33 (Suppl. 5), 51-56 (2010).
5. Hegedus, L. Clinical practice. The thyroid nodule. N. Engl. J. Med. 351, 1764-1771 (2004).
6. Griffith, O. L., Chiu, C. G., Gown, A. M., Jones, S. J. & Wiseman, S. M. Biomarker panel diagnosis of thyroid cancer: a critical review. Expert Rev. Anticancer Ther. 8, 1399-1413 (2008).
7. Cheung, C. C., Ezzat, S., Freeman, J. L., Rosen, I. B. & Asa, S. L. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod. Pathol. 14, 338-342 (2001). (Pubitemid 32298919)
8. Cheng, S., Serra, S., Mercado, M., Ezzat, S. & Asa, S. L. A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin. Cancer Res. 17, 2385-2394 (2011).
9. Nikiforov, Y. E. et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J. Clin. Endocrinol. Metab. 94, 2092-2098 (2009).
10. Ohori, N. P. et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance". Cancer Cytopathol. 118, 17-23 (2010).